Opinion

Video

Cardiometabolic Medicine: Seeing the Patient as a Whole

Author(s):

Pam Taub, MD, FACC, FASPC,Michael Koren, MD, FACC

The panelists stress the significance of a comprehensive approach to patient care, acknowledging the interconnected nature of cardiovascular, kidney, endocrine, and obesity-related benefits, and highlighting that addressing secondary diseases can minimize overall disease risk in patients.

Related Videos
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
HCPLive Lipoprotein Apheresis Special Report thumbnail
Linda Gillam, MD, MPH | Credit: Atlantic Health System
Linda Gillam, MD, MPH | Credit: Atlantic Health System
A panel of 3 experts on atopic dermatitis
Related Content
Hiddo Heerspink, PharmD, PhD | Credit: George Institute for Global Health
October 25th 2024

Semaglutide Shows Promise, Reduces UACR in Nondiabetic Kidney Disease

Patrick Campbell
Taher Modarressi, MD | Credit: X.com
October 3rd 2024

Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MD

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Ahmad Masri, MD, MS, director of the Hypertrophic Cardiomyopathy Center at Oregon Health and Science University
October 23rd 2024

Ahmad Masri, MD, MS: Establishing Proof-of-Concept of Gene Editing in ATTR-CM

Victoria Johnson
default thumbnail for Don't Miss a Beat podcast.
September 2nd 2024

Don't Miss a Beat: Finerenone's Role in Heart Failure from ESC Congress Data

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Adding Depression to Cardiovascular Risk Scores Offers Minimal Predictive Benefit
October 21st 2024

Adding Depression to Cardiovascular Risk Scores Offers Minimal Predictive Benefit

Chelsie Derman
Patients with Major Depressive Disorder Have Increased Triglyceride Levels
October 19th 2024

Patients with Major Depressive Disorder Have Increased Triglyceride Levels

Chelsie Derman
© 2024 MJH Life Sciences

All rights reserved.